Pharmaceutical manufacturers are mobilising to rapidly produce treatments, tests and vaccines, which means the need to safeguard data integrity has become even more critical. The pandemic is also putting pressure on manufacturers to deliver at pace increasing risk. Here Hannah Bailey, Business Development Director of Intoware, explains how digitalisation is meeting these challenges.
workforce
Covid-19 continues to devastate communities the world over, with over stretched healthcare battling to save lives. Against this backdrop there has been intense scrutiny of the pharma industry’s ability to develop vaccines and treatments to combat the virus and provide the path to recovery.
In a short time, the pandemic has increased our dependency on technology and pharma companies are investigating digital solutions to help unlock greater productivity. This is much needed as the industry had been cautious in applying digital solutions to improve manufacturing operations, despite the challenges of global competition, cost competitiveness and now Covid-19.